Dr. Ke Jian Liu's lab at Stony Brook University focuses on understanding how intracerebral hemorrhage (ICH) causes brain damage, specifically through a compound called zinc protoporphyrin (ZnPP). Their research investigates the relationship between tissue hypoxia, oxidative stress, and ZnPP formation in the brain after hemorrhage. The lab aims to explore whether repurposing certain FDA-approved drugs can provide new therapeutic options to reduce brain injury caused by ICH.